Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Launches First Overseas Office In Beijing

This article was originally published in The Pink Sheet Daily

Executive Summary

Eight FDA staffers in three offices face language, volume challenges watchdogging 500 plus Chinese firms exporting drug components to the U.S.
Advertisement

Related Content

FDA Posts OCI Agent In Singapore, But Other Foreign Offices Close
FDA Closing Office In Jordan To Better Leverage Shrinking Resources
FDA To Close Office In Amman, Jordan; Operations Moving To White Oak
FDA Inspection Growth In China Stymied By Visa Issues
FDA Overseas Staff Lacks Coordination With Agency's Centers, GAO Says
FDA Overseas Staff Lacks Coordination With Agency's Centers, GAO Says
U.S. Congress Expands Probe Into Ranbaxy’s AIDS Drugs Supplied To Developing Nations
Ranbaxy Internal Audit Disclosure Highlights U.S. FDA Policy Exceptions
Chinese Contaminant Was Inexpensive Heparin Mimic – U.S. FDA

Topics

Advertisement
UsernamePublicRestriction

Register

PS067044

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel